Stem cell differentiation and human liver disease

doi:10.3748/wjg.v18.i17.2018

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5810)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

525

HTML

5025

Figures (1-3)

260

Sum=5810

May 7, 2012 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 7, 2012; 18(17): 2018-2025
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2018

Full Size Figure Download Figure

Figure 2 Human liver cells in drug discovery[7,53,66,67]. Drug development process is a lengthy and expensive process. The derivation of hepatocyte-like cells from different human genotypes may provide novel in-vitro models for the screening of new compounds in the drug discovery process.

Citation: Zhou WL, Medine CN, Zhu L, Hay DC. Stem cell differentiation and human liver disease. World J Gastroenterol 2012; 18(17): 2018-2025
URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2018.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2018